Published in Gene Therapy Weekly, January 2nd, 2003
F. Gattacceca and colleagues, University of Paris, "constructed an E1E3-deleted replication-defective recombinant Ad carrying the human IFN-gamma gene (Ad-IFN-gamma) and tested its activity in vitro on HM cell lines established in [their] laboratory and in a nude mice model."
The researchers found that "in vitro, infection of HM cells with Ad-IFNgamma led to a prolonged production of an active cytokine in the 10 HM cell lines tested and also led to an antiproliferative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.